# Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

Study · id `cardio:ct-nct01550588` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01550588](<https://clinicaltrials.gov/study/NCT01550588>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01550588

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

## Technical summary

Registry record NCT01550588. Randomized; single masking; primary purpose prevention. Start 2012-02 (registry gives no type); primary completion 2020-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT01550588, source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01550588, source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)
- Primary completion: 2020-02 (anticipated) (ClinicalTrials.gov record NCT01550588, source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)
- Completion: 2020-02 (anticipated) (ClinicalTrials.gov record NCT01550588, source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01550588, source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01550588-2017-06-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)
- Condition: Patent Foramen Ovale
- Intervention (Device): Device closure
- Intervention (Drug): Standard medical treatment
- Lead sponsor: Jae-Kwan Song
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 8f0ec1aebd3bd46e20a724fe880e4346b4970b67587dd5a8be7554f2cef2bdf9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
